引用本文:覃桂芳,李友琼,卢秋维,罗焰芳,夏莉莉.EB病毒Rta-IgG定量检测试剂盒分析性能评估及其在鼻咽癌血清诊断学中的应用[J].中国临床新医学,2013,6(10):942-944.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1860次   下载 1161 本文二维码信息
码上扫一扫!
分享到: 微信 更多
EB病毒Rta-IgG定量检测试剂盒分析性能评估及其在鼻咽癌血清诊断学中的应用
覃桂芳,李友琼,卢秋维,罗焰芳,夏莉莉
530021 南宁,广西壮族自治区人民医院检验科
摘要:
[摘要] 目的 探讨EB病毒Rta蛋白IgG抗体在鼻咽癌诊断中的临床价值。方法 采用间接ELISA法检测612例临床样本中EB病毒Rta-IgG含量,同时对试剂盒的分析性能进行评估。结果 267例鼻咽癌样本的EB病毒Rta-IgG抗体浓度为(77.64±3.205)U/ml,检测灵敏度为94.7%(214/226),特异度为86.3%(333/386),正确率为89.4%(547/612);255例健康体检血样抗体浓度为(8.31±0.745)U/ml;20例肝癌样本抗体浓度为(7.14±1.111)U/ml;30例肝炎样本抗体浓度为(7.40±0.581)U/ml;20例自身免疫病样本抗体浓度为(13.97±6.943)U/ml;20例鼻咽息肉样本抗体浓度为(12.58±6.197)U/ml。各组EB病毒Rta-IgG含量比较差异有统计学意义(P<0.05)。结论 EB病毒Rta-IgG定量检测试剂盒用于鼻咽癌诊断具有较高的临床价值,为进一步研究鼻咽癌患者治疗效果与患者血清中EB病毒Rta-IgG的含量的关系奠定了基础。
关键词:  EB病毒Rta-IgG  定量检测  鼻咽癌  诊断
DOI:10.3969/j.issn.1674-3806.2013.10.05
分类号:R 730.4
基金项目:广西卫生厅科研课题(编号:桂卫Z2010248)
Performance evaluation of EB virus Rta-IgG quantitative detection kit and its application in diagnosing nasopharyngeal carcinoma
QIN Gui-fang,LI You -qiong,LU Qiu-wei,et al.
Department of Clinical Laboratory, the People′s Hoespital of Guangxi Zhuang Autonomous Regiom,Nanning 530021,China
Abstract:
[Abstract] Objective To investigate the clinical value of Epstein-Barr virus (EBV) Rta/IgG in the diagnosis of nasopharyngeal carcinoma(NPC).Methods Sera from 612 clinical samples were measured for the Rta-IgG by an indirect enzyme-linked immunosorbent assay. In the present study, we also evaluated the performance of the Rta-IgG ELISA kits.Results The mean value of Rta-IgG concentration in 267 NPC patients was (77.64±3.205)U/ml with a sensitivity of 94.7%(214/226) and specificity of 86.3%(333/386) and accuracy of 89.4%(547/612). The mean value of Rta-IgG concentration in 255 healthy volunteers,20 hepatocellular carcinoma patients,30 hepatitis patients,20 patients with autoimmune disease and 20 patients with nasopharyngeal polyp were (8.31±0.745)U/ml, (7.14±1.111)U/ml, (7.40±0.581)U/ml, (13.97±6.943)U/ml and (12.58±6.197)U/ml, respectively. There were significant difference between NPC group and other groups.Conclusion Our results suggest that the EBV Rta/IgG ELISA kit is suitable for the clinical diagnosis of NPC. It also provides a basis for further study on the relationship between the therapeutic effect and serum EBV Rta-IgG content in NPC patients.
Key words:  EBV Rta-IgG  Quantitative detection  Nasopharyngeal carcinoma(NPC)  Diagnosis